DRUGS AND THERAPEUTIC INFORMATION SERVICE PROVIDED BY CLINICAL PHARMACISTS FOR AN IMPROVED PATIENT CARE: AN EXPERIENCE FROM A TERTIARY CARE TEACHING HOSPITAL
Objective: To assess the quality of drug information (DI) services provided by clinical pharmacists in a South Indian tertiary care teaching hospital.
Methods: All answered DI queries by the Department of Clinical Pharmacy are documented electronically. To assess the quality of DI services, a
quality assessment panel was constituted comprising the senior clinical pharmacists, and a quality assessment checklist was developed and applied
for assessing the quality of DI services.
Results: During the 12-month study period, a total of 1204 DI queries were received. The majority (48.76%) of DI queries was received during ward
rounds by the clinical pharmacists and among them 61% of the queries was for better patient care. The highest numbers of queries (48%) were
received from post-graduate medical students followed by the physicians (16%) and interns (8%). The most common DI queries were requested to
know the dosage/administration (22%), followed by cancer chemotherapy dosing (15.70%), adverse drug reactions (8%), drug use in pregnancy/
lactation (7.56%), and drug-drug interactions (6.48%). The highest number of queries were from Department of Medicine (26%) followed by Surgery
Department (19.35%), Department of Pediatrics (15.61%) and Department of Dermatology (8.47%). The majority of the queries were answered
immediately (64%). As per the quality assessment checklist, 64.5% queries were rated as excellent in quality followed by good (35.8%) and only 3.5%
DI queries were required improvement.
Conclusion: The quality of DI service was found satisfactory based on the rating.
Keywords: Drug Information, Quality Assurance, Clinical Pharmacists, Medicine Information
Hepler CD, Strand LM. Opportunities and responsibilities in
pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
Rovers J, Currie J, Hagel H. The case for pharmaceutical care. In:
A Practical Guide to Pharmaceutical Care. 2
ed. Washington, DC:
American Pharmacists Association; 2003. p. 3-4.
Daly AK. Individualized drug therapy. J Curr Opin Drug Discov Dev
Rosenberg M, Koumis T, Nathan JP, Cicero LA, McGuire H. Current
status of pharmacist operated drug information centers in the United
States. J Am J Health Syst Pharm 2004;61(19):2023-32.
Bond CA, Cynthia L, Franke T. Clinical pharmacy services, hospital
pharmacy staffing, and medication errors in United States hospitals.
Monson R, Bond CA, Schuna A. Role of the clinical pharmacist in
improving drug therapy. Clinical pharmacists in outpatient therapy.
Arch Intern Med 1981;141(11):1441-4.
Cooper G. Developing the skills and attributes of a clinical pharmacist
within a master of pharmacy curriculum. J Pharm Pract Res
Schatz R, Belloto RJ Jr, White DB, Bachmann K. Provision of drug
information to patients by pharmacists: The impact of the Omnibus
Budget Reconciliation Act of 1990 a decade later. Am J Ther
Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists
on rounding teams reduce preventable adverse drug events in hospital
general medicine units. Arch Intern Med 200;163(17):2014-8.
Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists
and inpatient medical care: A systematic review. Arch Intern Med
How to Cite
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.